A Study to Assess the Efficacy and Safety of ABTL0812

Clinical trial NCT03366480 · COMPLETED

Trial details

NCT number: NCT03366480
Sponsor: Ability Pharmaceuticals SL
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Squamous Non-Small Cell Lung Cancer

Start date: 2016-12-01
Primary completion: 2020-06-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.